SNTA1 Gene LQTS Type 12 Genetic Test in UAE | AED 2800

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post‑Test Clinical Guidance by DHA‑Licensed Consultant Medical Geneticist.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

This Next‑Generation Sequencing (NGS) test analyzes the SNTA1 gene for mutations causing Long QT Syndrome type 12, a cardiac ion channelopathy that can lead to ventricular arrhythmias and sudden cardiac death. It is recommended for individuals with a family history of LQTS, unexplained syncope, or a prolonged QT interval on ECG.

Feature	Our Test (NGS)	Single‑Gene Sanger Sequencing
Precision / Depth	99.9% diagnostic sensitivity, full coding region ± 20 bp splice sites	~99.0% sensitivity; limited to known hotspots
Methodology	Next‑Generation Sequencing (Illumina NovaSeq™), confirmed by Sanger	Sanger Sequencing only
Turnaround Time	3–4 Weeks	4–6 Weeks
Cost	AED 2,800	~AED 3,500

Physician Insight & Safety Protocols

“This genetic test provides important risk stratification for Long QT syndrome type 12, but a negative result does not rule out other genetic or acquired forms. Always correlate with a 12‑lead ECG, thorough family history, and clinical evaluation. Do not alter therapy without specialist input.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License: 9294403

⛔ Do not discontinue prescribed medication without consulting your doctor.

Patient Safety & Exclusion Criteria

Exclusion: Not a standalone screening tool; pre‑ and post‑test genetic counselling is mandatory.
Minors: Testing in children <16 years requires parental consent and clinical indication per Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Emergency Red Flags: If you experience new‑onset palpitations, syncope, seizure‑like activity, or cardiac arrest before/during test, go to the ER immediately.
Data Privacy: All samples and genetic data are protected under Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

Important Advisory

This test is not a substitute for comprehensive cardiac evaluation. Results should be interpreted in conjunction with clinical findings, family history, and ECG data. Hospital extraction only if specimen requires invasive procedure – not applicable here.

Patient FAQ & Clinical Guidance

1. What is the SNTA1 gene Long QT syndrome type 12 test?

It is a genetic test that analyzes the SNTA1 gene for mutations associated with Long QT syndrome type 12, a heart rhythm disorder that can lead to dangerous arrhythmias.

2. How should I prepare for the test?

No fasting is required. A blood, saliva, or FTA card sample will be collected at your home by our DHA‑licensed phlebotomist. You will receive a pre‑test genetic counselling session to document your family history.

3. When will I get my results and who explains them?

Results are typically available within 3‑4 weeks. A DHA‑licensed Consultant Medical Geneticist will provide a telephonic consultation to explain the implications and recommend next steps.

4. Can this test detect all types of Long QT syndrome?

No, this test specifically targets SNTA1 mutations for LQTS type 12. Other genetic causes of LQTS require separate panel testing. Always discuss with your cardiologist.

UAE Regulatory & Data Privacy Adherence

Compliance Framework

This test adheres to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety follows Federal Decree‑Law No. 4 of 2016 on Medical Liability. The facility is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139) and all genetic counselling is provided by DHA‑licensed professionals.

Clinical & Logistical Metadata

Test Name	SNTA1 Gene Long QT Syndrome Type 12 Genetic Test
Price (AED)	AED 2,800
Turnaround Time	3–4 Weeks
Sample Type / Matrix	Blood, Saliva, or FTA Card (VIP Mobile Phlebotomy available)
Methodology Used	Next‑Generation Sequencing (Illumina NovaSeq™) with Sanger confirmation
ICD-10-CM Code	I45.81
LOINC Code	94759-3
DHA Facility License & Laboratory Address	DHA License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE)